Pharmacokinetics and Pharmacodynamics of Biotech Drugs
Principles and Case Studies in Drug Development
(Sprache: Englisch)
This first ever coverage of the pharmacokinetic and pharmacodynamic characteristics of biopharmaceuticals meets the need for a comprehensive book in this field. It spans all topics from lead identification right up to final-stage clinical trials.
Following...
Following...
Leider schon ausverkauft
versandkostenfrei
Buch (Gebunden)
179.00 €
89 DeutschlandCard Punkte
sammeln
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
- Ratenzahlung möglich
Produktdetails
Produktinformationen zu „Pharmacokinetics and Pharmacodynamics of Biotech Drugs “
Klappentext zu „Pharmacokinetics and Pharmacodynamics of Biotech Drugs “
This first ever coverage of the pharmacokinetic and pharmacodynamic characteristics of biopharmaceuticals meets the need for a comprehensive book in this field. It spans all topics from lead identification right up to final-stage clinical trials.Following an introduction to the role of PK and PD in the development of biotech drugs, the book goes on to cover the basics, including the pharmacokinetics of peptides, monoclonal antibodies, antisense oligonucleotides, as well as viral and non-viral gene delivery vectors. The second section discusses such challenges and opportunities as pulmonary delivery of proteins and peptides, and the delivery of oligonucleotides. The final section considers the integration of PK and PD concepts into the biotech drug development plan, taking as case studies the preclinical and clinical drug development of tasidotin, as well as the examples of cetuximab and pegfilgrastim.
The result is vital reading for all pharmaceutical researchers.
Inhaltsverzeichnis zu „Pharmacokinetics and Pharmacodynamics of Biotech Drugs “
INTRODUCTION- The role of PK and PD in the development of biotech drugs.
THE BASICS
- Pharmacokinetics of peptides
- Pharmacokinetics of monoclonal antibodies
- Pharmacokinetics and pharmacodynamics of antisense oligonucleotides
- Pharmacokinetics of viral and non-viral gene delivery vectors
CHALLENGES AND OPPORTUNITIES
- Bioanalytical methods used for PK evaluations biotech drugs
- Limitations of noncompartmental analysis of biotech drugs
- Bioequivalence assessments for biotech drugs
- Biopharmaceutical challenges in pulmonary delivery of proteins and peptides
- Biopharmaceutical challenges: delivery of Oligonucleotides
- Custom-tailored PK and PD via chemical and pharmaceutical modifications of biotech drugs
- Exposure-response correlations for biotech drugs
- Pharmacogenetics and biotech drugs
INTEGRATION OF PK AND PD CONCEPTS INTO THE BIOTECH DRUG DEVELOPMENT PLAN
- Preclinical and clinical drug development of tasidotin
- Example: Clinical drug development of an antibody-based biotech drug: cetuximab
- Example: Clinical drug development of a peptide-based biotech drug: pegfilgrastim
Autoren-Porträt
Bernd Meibohm is an Associate Professor of Pharmaceutical Sciences at the College of Pharmacy of the University of Tennessee Health Science Center, Memphis. He obtained his PhD from the University Carolo-Wilhelmina in Braunschweig, Germany, and underwent postdoctoral training in clinical pharmacology at the University of Florida, Gainesville. His research is focused on pharmacokinetics (PK), pharmacodynamics (PD), and pharmacogenetics (PG) with special emphasis on PK/PD/PG correlations. Professor Meibohm is a Fellow of the American College of Clinical Pharmacology (ACCP) and has received numerous awards, including the 'Young Investigator Award in PK, PD and Drug Metabolism' from the American Association of Pharmaceutical Scientists (AAPS) in 2000. He is currently serving as Section Editor for PK and PD for the 'Journal of Clinical Pharmacology' and on the Editorial Boards of the 'Journal of Pediatric Pharmacology and Therapeutics' and 'Die Pharmazie'.
Bibliographische Angaben
- 2006, 1. Auflage, XXII, 404 Seiten, 121 Schwarz-Weiß-Abbildungen, mit Abbildungen, Maße: 17,7 x 24,6 cm, Gebunden, Englisch
- Herausgegeben: Bernd Meibohm
- Verlag: Wiley-VCH
- ISBN-10: 3527314083
- ISBN-13: 9783527314089
Sprache:
Englisch
Rezension zu „Pharmacokinetics and Pharmacodynamics of Biotech Drugs “
"... There is an urgent need to understand the PK and PD characteristics of these different types of drugs. This book meets that need. ..."Anticancer Research
Pressezitat
"... There is an urgent need to understand the PK and PD characteristics of these different types of drugs. This book meets that need. ..."Anticancer Research
Kommentar zu "Pharmacokinetics and Pharmacodynamics of Biotech Drugs"
0 Gebrauchte Artikel zu „Pharmacokinetics and Pharmacodynamics of Biotech Drugs“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Pharmacokinetics and Pharmacodynamics of Biotech Drugs".
Kommentar verfassen